FR2435039A1 - Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi - Google Patents

Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi

Info

Publication number
FR2435039A1
FR2435039A1 FR7921528A FR7921528A FR2435039A1 FR 2435039 A1 FR2435039 A1 FR 2435039A1 FR 7921528 A FR7921528 A FR 7921528A FR 7921528 A FR7921528 A FR 7921528A FR 2435039 A1 FR2435039 A1 FR 2435039A1
Authority
FR
France
Prior art keywords
composition
preparation
microglobulin
determining human
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921528A
Other languages
English (en)
Other versions
FR2435039B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of FR2435039A1 publication Critical patent/FR2435039A1/fr
Application granted granted Critical
Publication of FR2435039B1 publication Critical patent/FR2435039B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Composition permettant de doser la microglobuline- beta 2 humaine, par exemple dans le sérum ou dans l'urine. Elle est constituée de particules de latex polymère synthétique et d'un anticorps anti-microglobuline- beta 2 humaine revêtant les surfaces des particules de latex. Cette composition est utile pour le diagnostic de certaines maladies, telles que la leucémie, certaines affections rénales et certaines maladies inflammatoires.
FR7921528A 1978-08-28 1979-08-28 Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi Granted FR2435039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10389078A JPS5530652A (en) 1978-08-28 1978-08-28 Latex sensitive to antibody of human beta2-microglobulin for quantitizing human beta2-microglobulin and its composite

Publications (2)

Publication Number Publication Date
FR2435039A1 true FR2435039A1 (fr) 1980-03-28
FR2435039B1 FR2435039B1 (fr) 1984-02-24

Family

ID=14366013

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921528A Granted FR2435039A1 (fr) 1978-08-28 1979-08-28 Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi

Country Status (6)

Country Link
JP (1) JPS5530652A (fr)
CH (1) CH645727A5 (fr)
DE (1) DE2934756C2 (fr)
FR (1) FR2435039A1 (fr)
GB (1) GB2030294B (fr)
SE (1) SE446130B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109975550A (zh) * 2018-12-29 2019-07-05 宁波普瑞柏生物技术股份有限公司 消除β2-微球蛋白检测中钩状效应的方法和试剂盒

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59224565A (ja) * 1983-04-28 1984-12-17 Morinaga Milk Ind Co Ltd 抗原検出用試薬
US4575486A (en) * 1983-10-26 1986-03-11 International Remote Imaging Systems, Inc. Process for differentiating the origin of particles in urine
WO1987001597A1 (fr) * 1985-09-19 1987-04-26 Toray Industries, Inc. COLONNE D'EXTRACTION DE beta2-MICROGLOBULINE
US5175113A (en) * 1986-01-16 1992-12-29 Novo Nordisk A/S Modified β2 -microglobulin
DK160944C (da) * 1986-01-16 1991-10-21 Novo Industri As Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse
EP0247592B1 (fr) * 1986-05-30 1992-03-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant pour microglobuline bêta 2 et chaîne d'immunoglobuline L
NL8602915A (nl) * 1986-11-17 1988-06-16 Innogenetics Nv Werkwijze en diagnostisch middel voor het diagnostiseren en/of prospectief volgen van letsel ter hoogte van de pulmonaire microcirculatie.
US20020164818A1 (en) 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
CN108872590A (zh) * 2018-06-29 2018-11-23 宁波海壹生物科技有限公司 可同时检测血清和尿液样本中β2-微球蛋白的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088875A (en) * 1959-10-27 1963-05-07 Hyland Lab Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron
NL125235C (fr) * 1965-04-15
GB1384399A (en) * 1971-02-01 1975-02-19 Hoffmann La Roche Automated method of obtaining serological data

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109975550A (zh) * 2018-12-29 2019-07-05 宁波普瑞柏生物技术股份有限公司 消除β2-微球蛋白检测中钩状效应的方法和试剂盒

Also Published As

Publication number Publication date
SE446130B (sv) 1986-08-11
SE7907118L (sv) 1980-02-29
DE2934756C2 (de) 1984-11-08
FR2435039B1 (fr) 1984-02-24
GB2030294A (en) 1980-04-02
JPS5530652A (en) 1980-03-04
DE2934756A1 (de) 1980-03-13
CH645727A5 (de) 1984-10-15
GB2030294B (en) 1983-03-02

Similar Documents

Publication Publication Date Title
Alper et al. Human C′ 3: evidence for the liver as the primary site of synthesis
Trengove et al. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers
FR2399662A1 (fr) Produit pour le dosage du glucose, notamment dans le sang ou le serum
FR2435039A1 (fr) Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi
Nevalainen et al. Synovial‐type (group II) phospholipase A2 human seminal plasma
Kurzrock Cytokine deregulation in hematological malignancies: clinical and biological implications.
Saito et al. Effects of a selective thromboxane A2 synthetase inhibitor on immune complex glomerulonephritis
RU2218178C2 (ru) Антитела против фосфорилированного vasp (стимулированного вазодилататором фосфопротеина), гибридомные клетки для их получения и их применение
Denholm et al. Secretion of monocyte chemotactic activity by alveolar macrophages.
FR2435040A1 (fr) Composition pour determiner l'immunoglobuline g humaine, procede pour sa preparation et son emploi
Braathen et al. Immunological in situ identification of the lymphoid cells in the skin infiltrate of lichen planus
Dąbrowski et al. Immunoelectron microscopic studies in IgA linear dermatosis
Fleer et al. Correlation of PPD and BCG‐induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man
SU1013853A1 (ru) Способ определени воспалительного процесса в организме
Kuizenga et al. The bioassay of heparin preparations
Heyns et al. Platelet aggregation in chronic idiopathic thrombocytopenic purpura.
Skauo Proteins in fluid from non‐keratinizing jaw cysts. 2. Concentrations of total protein, some protein fractions and nitrogen
Thomas et al. Simplified immunoradiometric assay for factor VIII coagulant antigen
Østergaard et al. Whole salivary immunoglobulin levels in 60 healthy children: determined by a sensitive electroimmuno technique after prior carbamylation
Haglid et al. Lactate dehydrogenase isoenzymes and proteins in human gliomas
DE3780446T2 (de) Verfahren zur feststellung von schwangerschaftsstoerungen.
Davies et al. Effect of glomerular basement membrane on the initiation of chemiluminescence and lysosomal enzyme release in human polymorphonuclear leucocytes: an in vitro model of glomerular disease.
Freeman The anticoagulant effect of bacterial polysaccharides in normal and thrombocytopenic plasma of leukemia
Markarian et al. Comparison of the kinetics of clot formation, fibrinogen, fibrinolysis, and hematocrit in pregnant women and adults
DeChatelet et al. Absence of measurable leukocyte alkaline phosphatase activity from leukocytes of patients with chronic granulocytic leukemia

Legal Events

Date Code Title Description
ST Notification of lapse